SHARE (Study to Help the AIDS Research Effort) is recruiting.
HIV-negative and HIV-positive MEN
For the first time in 19 years, the SHARE study is recruiting new participants. SHARE is part of the longest-running and largest HIV research study in the U.S. This is a unique opportunity to contribute to the knowledge of HIV infections and HIV therapy over a lifetime. SHARE is NOT a treatment study and does NOT involve taking experimental medicines. You will continue to receive your medical care from your own medical care provider.
- Males 30 years of age or older
- 2 initial visits:
Screening visit – an initial screening visit about 30 minutes long. If you are eligible, you will be given an appointment for an enrollment visit.
Baseline Enrollment visit – a full visit about 2-3 hours long and includes $100 compensation for your time and effort.
- If eligible for enrollment, you will be asked to complete one study visit annually. Each study visit lasts 2-3 hours and includes:
- Remote or in-person interviews
- Lab testing (for HIV, viral load, and other infections like hepatitis)
- Physical exams and health referrals
BENEFITS OF JOINING
- Help researchers better understand HIV and AIDS and the long-term effects of HIV medicines
- Free and confidential laboratory testing (includes T cell count and viral load)
- Free physical exams and health referrals
- Flexible scheduling, including evenings and weekends in Baltimore or DC
- A friendly, supportive environment with light refreshments
To volunteer or for more information, please contact the SHARE study at 410-955-7090 or 1-866-392-8991 or 202-745-6137.